Clinical Trials Browser

Phase 3 × INDUSTRY × Glutamine × Clear all

NCT01179217 2020-08-19

A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia

Phase 3 Completed

230 enrolled 19 charts 1 FDA

Classical hematology

Vaso-Occlusive Crises, Anemia, Sickle Cell

NCT01087658 2013-06-21

GLUTOX

Phase 3 Completed

Gastrointestinal

Colorectal Neoplasms

NCT00455247 2013-06-05

Efficacy of an Oral Formula in Prevention of Anti-cancer Therapy Side Effects

Phase 3 Completed

Gastrointestinal

Gastrointestinal Neoplasms